US medical groups issue fall vaccine guidelines
Analysis based on 29 articles · First reported Sep 02, 2026 · Last updated Sep 03, 2026
The coordinated guidelines could boost vaccine uptake, benefiting manufacturers like Moderna, Pfizer, Novavax, and Sanofi, and pharmacies such as Walgreens. The move may also pressure federal agencies to align with these recommendations, potentially stabilizing the vaccine market and reducing confusion among consumers and insurers.
Leading U.S. medical organizations, including the American Medical Association, American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America, jointly issued updated fall vaccination guidelines for flu, COVID-19, and RSV. They aim to provide clear, science-based recommendations amid confusion caused by the Trump administration's rollback of federal vaccine guidance and a court battle over the CDC's advisory committee. The groups recommend flu vaccination for nearly everyone aged 6 months and older, COVID-19 shots for all adults and high-risk children, and RSV vaccination for older adults and pregnant women. They also highlight the FDA's approval of Moderna's new mRNA flu vaccine mFlusiva for adults 50 and older, which showed 27% greater efficacy than standard shots. The guidelines are supported by data from the Vaccine Integrity Project published in JAMA, showing reduced hospitalizations from vaccination.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard